{"paper_id": "32a76c6098177841292dd6c2fe22aaee715e97ca", "metadata": {"title": "Electronic Companion to: Operational Issues and Network Effects in Vaccine Markets A.1 An SIR Model with Vital Dynamics (Endemic Model)", "authors": [{"first": "Elodie", "middle": [], "last": "Adida", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Debabrata", "middle": [], "last": "Dey", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Hamed", "middle": [], "last": "Mamani", "suffix": "", "affiliation": {}, "email": ""}]}, "abstract": [{"text": "The analysis presented in the paper, relies on an underlying epidemic model to obtain the infection probability r(f). This appendix presents two variants of the textbook SIR epidemic model, one with vital dynamics and one without. We derive a closed form solution for infection probability of an SIR model with vital dynamics which gives rise to the formulas used in the paper. Unfortunately, for an SIR model without vital dynamics, there is no closed-form solution. However, we show that, for diseases of interest and for realistic values of infection model parameters, the same formula can be used as an effective approximation for the true probability function. Using the notation in the paper, a vaccine's effectiveness is denoted by a parameter \u03c6, where 0 < \u03c6 \u2264 1.", "cite_spans": [], "ref_spans": [], "section": "Abstract"}], "body_text": [{"text": "In this model, births and deaths are explicitly taken into account. The birth and death rates are equal so that the total size of the population would remain constant. Notice that such models can be used for diseases which can stay in the population for a long time period (e.g., smallpox), but may not be appropriate for diseases that can invade a population for a relatively short period of time (e.g., influenza).", "cite_spans": [], "ref_spans": [], "section": "A.1 An SIR Model with Vital Dynamics (Endemic Model)"}, {"text": "A standard formulation for the SIR epidemic with vital dynamics (endemic model) uses a three-compartment model in which individuals are either susceptible to the disease (S), infectious (I), or recovered (R). The fractions of individuals in these three states at time t are represented as S(t), I(t), and R(t), respectively. When expressed as a set of differential equations, epidemiologists tend to parameterize the endemic model by:", "cite_spans": [], "ref_spans": [], "section": "A.1 An SIR Model with Vital Dynamics (Endemic Model)"}, {"text": "where \u03b3 is the birth and death rate, \u03b2 is the mean transmission rate, and \u03b4 > 0 is the mean duration of the infection; clearly, \u03b3\u03b4 is then the infectious period as a fraction of mean lifetime Let R 0 = \u03b2\u03b4 \u03b3\u03b4+1 be the basic reproduction number and F = R0\u22121 \u03c6R0 be the critical vaccination fraction. Let\u015c and\u00ce be the number of susceptible and infected individuals (vaccinated and unvaccinated) in the population in the equilibrium. One can show that if f \u2265 F , then the system converges to the disease-free state (\u015c,\u00ce) = (1 \u2212 \u03c6f, 0), whereas if f < F , then the system converges to the following stable endemic state (\u015c,\u00ce) = 1 \u2212 \u03c6f, \u03c6\u03b3\u03b4 \u03b3\u03b4+1 (F \u2212 f) (Bauch and Earn 2004). As a result, the infection probability of a susceptible individual can be expressed as the proportion of susceptible individuals becoming infected versus dying in any unit of time. Therefore, the total fraction of infected individuals in the population is:", "cite_spans": [], "ref_spans": [], "section": "A.1 An SIR Model with Vital Dynamics (Endemic Model)"}, {"text": "which is the same as the probability function presented in the paper.", "cite_spans": [], "ref_spans": [], "section": "A.1 An SIR Model with Vital Dynamics (Endemic Model)"}, {"text": "This is an epidemic model which does not include newborns or regular deaths in the population due to the relatively small window of the infection period. This model has been shown to be consistent with history of many diseases including influenza. As a result, letting \u03b3 = 0 in the above-mentioned system of differential equations leads to:", "cite_spans": [], "ref_spans": [], "section": "A.2 An SIR Model without Vital Dynamics (Epidemic Model)"}, {"text": "Timely vaccination followed by the onset of (instantaneous) infections from exogenous sources results in initial conditions", "cite_spans": [], "ref_spans": [], "section": "A.2 An SIR Model without Vital Dynamics (Epidemic Model)"}, {"text": "where \u03c7 is the initial infected fraction of the population. As expected, this number is typically very small (0 < \u03c7 1). It can be shown that the attack rate in this case does not have an explicit form solution like the previous section. However, it can be approximated as follows (Chick et al. 2008) :", "cite_spans": [{"start": 280, "end": 299, "text": "(Chick et al. 2008)", "ref_id": null}], "ref_spans": [], "section": "A.2 An SIR Model without Vital Dynamics (Epidemic Model)"}, {"text": "Moreover, it can be shown that the critical vaccination fraction for this case is the same as the one for the endemic model, i.e., F = R0\u22121 R0\u03c6 , where R 0 = \u03b2\u03b4 is the basic reproduction number. Chick et al. (2008) also argue that, for a small enough value of \u03c7, the overall infected fraction of the population, r(f), can be well estimated by a piecewise linear function. Using the first-order Taylor series approximation, we get:", "cite_spans": [], "ref_spans": [], "section": "A.2 An SIR Model without Vital Dynamics (Epidemic Model)"}, {"text": "which is identical to the endemic case.", "cite_spans": [], "ref_spans": [], "section": "A.2 An SIR Model without Vital Dynamics (Epidemic Model)"}, {"text": "In this appendix, we extend the SIR models developed in Appendix A to account for the disease dynamic within the vaccinated and unvaccinated populations. Such compartmental models are mainly discussed in the context of HIV and HPV vaccines in the epidemiology literature (Anderson and Hanson 2005 , Hughes et al. 2002 , McLean and Blower 1993 . In this section, we use a variant of the mentioned models to fit other diseases of interest such as influenza.", "cite_spans": [{"start": 271, "end": 296, "text": "(Anderson and Hanson 2005", "ref_id": "BIBREF0"}, {"start": 297, "end": 317, "text": ", Hughes et al. 2002", "ref_id": "BIBREF1"}, {"start": 318, "end": 342, "text": ", McLean and Blower 1993", "ref_id": "BIBREF2"}], "ref_spans": [], "section": "B Estimation of p(f )"}, {"text": "As before, we consider two variants of the SIR epidemic model, one with vital dynamics and one without. Unlike for the total fraction of the infected population, we are not able to find a closed-form analytical solution for the infection probability of vaccinated population. However, we can show that a simple piecewise linear function can provide a fairly effective approximation for p(f) for both scenarios.", "cite_spans": [], "ref_spans": [], "section": "B.1 An SIR model with imperfect vaccines"}, {"text": "In order to differentiate between the vaccinated and unvaccinated populations we define the following five states for the individuals at any time t. Let S n (t) be the fraction of unvaccinated susceptible individuals, I n (t) the fraction of unvaccinated infected individuals, S v (t) the fraction of vaccinated susceptible individuals, I v (t) the fraction of vaccinated infected individuals, and R(t) the fraction of recovered population. With imperfect vaccination and vital dynamics, assuming that vaccination occurs at birth, the system of differential equations characterizing the epidemic model can be written as:", "cite_spans": [], "ref_spans": [], "section": "B.1 An SIR model with imperfect vaccines"}, {"text": "Setting \u03b3 = 0 in the set of differential equations above would lead to the infection dynamics for an infection without vital dynamics:", "cite_spans": [], "ref_spans": [], "section": "B.1 An SIR model with imperfect vaccines"}, {"text": "Timely vaccination followed by the onset of (instantaneous) infections from exogenous sources results in initial conditions", "cite_spans": [], "ref_spans": [], "section": "B.1 An SIR model with imperfect vaccines"}, {"text": "where \u03c7 is the initial infected population who initiate the epidemic.", "cite_spans": [], "ref_spans": [], "section": "B.1 An SIR model with imperfect vaccines"}, {"text": "While we are not able to find a closed-form solution for the infection probability of the vaccinated population,", "cite_spans": [], "ref_spans": [], "section": "B.2 Further Approximation of p(f)"}, {"text": "I v (t)dt /f, in either one of the epidemic models, we can estimate this function numerically.", "cite_spans": [], "ref_spans": [], "section": "B.2 Further Approximation of p(f)"}, {"text": "Based on the numerical estimates, we find that, for a suitable choice of \u03b7, the following is a reasonably close approximation of p(f), both with and without vital dynamics:", "cite_spans": [], "ref_spans": [], "section": "B.2 Further Approximation of p(f)"}, {"text": "In Figure A1 , the actual values of p(f)-obtained from numerical solutions of the ODEs for the case without vital dynamics with R 0 = 2 and \u03c6 = 0.9-are plotted as points (represented by \u00d7). The approximation of p(f) is drawn as a solid line. In this particular case, the best fit is obtained for \u03b7 = 3.3. This figure clearly shows that our approximation is quite close to the reality. Similar plots were obtained for other values of R 0 and \u03c6, as well as for the case with vital dynamics.", "cite_spans": [], "ref_spans": [{"start": 3, "end": 12, "text": "Figure A1", "ref_id": "FIGREF0"}], "section": "B.2 Further Approximation of p(f)"}, {"text": "Proof of Theorem 1", "cite_spans": [], "ref_spans": [], "section": "C Proofs"}, {"text": "First, we assume that the vaccine is perfect. Then \u03c6 = 1 and the demand equation becomes w =F \u2212 f. Let t =F \u2212 f, and z = f q . Then, f =F \u2212 t, and q =F \u2212t z . Thus, we can rewrite the objective as:", "cite_spans": [], "ref_spans": [], "section": "C Proofs"}, {"text": "Taking the first derivatives with respect to z and t, we get:", "cite_spans": [], "ref_spans": [], "section": "C Proofs"}, {"text": "Define functions R(z) and S(t) as follows:", "cite_spans": [], "ref_spans": [], "section": "C Proofs"}, {"text": "We will shortly prove that R(z) has at most two roots between zero and its upper limit (\u016a ), when t is chosen such that S(t) = 0. Note that the roots of R(z) are the roots for \u2202\u03c0(t,z) \u2202z and vice versa; the same is true for S(t) and \u2202\u03c0(t,z) \u2202t . Setting S(t) = 0, and defining", "cite_spans": [], "ref_spans": [], "section": "C Proofs"}, {"text": "leads to:", "cite_spans": [], "ref_spans": [], "section": "C Proofs"}, {"text": "+F .", "cite_spans": [], "ref_spans": [], "section": "C Proofs"}, {"text": "Taking the derivative of R(z), we get:", "cite_spans": [], "ref_spans": [], "section": "Now, replace this t into the expression for R(z) in Equation (A1) to obtain:"}, {"text": "is the hazard rate of random variable U with a pdf j(z), a cdf J(z), and a complement cdf ofJ(z) = 1 \u2212 J(z). The second derivative of R(z) where its first derivative is zero can, then, be found:", "cite_spans": [], "ref_spans": [], "section": "Now, replace this t into the expression for R(z) in Equation (A1) to obtain:"}, {"text": "As a result, if (A3) is positive then we can conclude that R(z) can have at most two roots which is the desired result. To show this, we first prove that the portion marked as ( ) in (A3) is positive:", "cite_spans": [], "ref_spans": [], "section": "Now, replace this t into the expression for R(z) in Equation (A1) to obtain:"}, {"text": "On the other hand, setting S(t) to zero in (A2), we get:", "cite_spans": [], "ref_spans": [], "section": "Now, replace this t into the expression for R(z) in Equation (A1) to obtain:"}, {"text": "Thus, (A4) and the portion of (A3) marked as ( ) are both non-negative. As a result, (A3) is non-negative for distributions that satisfy 2\u03c1(z)J (z)+\u0398(z)\u03c1 (z) \u2265 0. Therefore the derivative of the objective function has at most two roots with the first one being the local maximum and the second one the local minimum. Next we show that the minimum is always outside of the feasible range of vaccination fractions, f \u2208 (0,F \u2212 c \u00b5 ) or equivalently t \u2208 ( c \u00b5 ,F ). To see this, we replace t = c \u00b5 in (A1):", "cite_spans": [], "ref_spans": [], "section": "Now, replace this t into the expression for R(z) in Equation (A1) to obtain:"}, {"text": "Now, if the vaccine is imperfect, we have:", "cite_spans": [], "ref_spans": [], "section": "Now, replace this t into the expression for R(z) in Equation (A1) to obtain:"}, {"text": "Thus, we can rewrite the objective as:", "cite_spans": [], "ref_spans": [], "section": "Now, replace this t into the expression for R(z) in Equation (A1) to obtain:"}, {"text": "The rest of the proof proceeds similarly to the perfect case above.", "cite_spans": [], "ref_spans": [], "section": "Now, replace this t into the expression for R(z) in Equation (A1) to obtain:"}, {"text": "Let q be the production quantity. We first prove that the derivative of \u0393 with respect to f, 0 \u2264 f \u2264F , is always non-positive. Using (??) , for all f, 0 \u2264 f \u2264F , we have:", "cite_spans": [], "ref_spans": [{"start": 134, "end": 138, "text": "(??)", "ref_id": null}], "section": "Proof of Theorem 2"}, {"text": "Now we consider two cases: (1)F \u2264 q\u016a and (2)F > q\u016a . For the first case using the inequality above we find f * =F . Under the second case however, for all q\u016a \u2264 f \u2264F , the integral and hence the derivative is zero. Defining the optimal fraction to be the smallest fraction optimizing the objective we get: f * = min{F ,\u016a q}.", "cite_spans": [], "ref_spans": [], "section": "Proof of Theorem 2"}, {"text": "Note that even though f * = min{F ,\u016aq}, in order to find the optimal q we can simply replace f byF in the \u0393(q, f) expression and achieve the same objective. Thus one can write the objective function as a function of q, only. Taking the first and second derivatives of the objective with respect to q, leads to:", "cite_spans": [], "ref_spans": [], "section": "Proof of Theorem 2"}, {"text": "Note that the term d dx (T (xq) + xqT (xq)) is non-positive, as the function fT (f) is concave. Furthermore, \u03c6 + T (F ) +F T (F ) \u2265 0 from above, making the second derivative non-negative. Thus, the first-order condition could be used to find the optimal q. If", "cite_spans": [], "ref_spans": [], "section": "Proof of Theorem 2"}, {"text": "then the objective is increasing over the entire set of feasible production quantities, and hence q * = 0. Otherwise, q * can be found by solving the first order condition:", "cite_spans": [], "ref_spans": [], "section": "Proof of Theorem 2"}, {"text": "which completes the proof.", "cite_spans": [], "ref_spans": [], "section": "Proof of Theorem 2"}, {"text": "Given a fixed contract (s, e), we first take the derivative of the manufacturer's cost", "cite_spans": [], "ref_spans": [], "section": "Proof of Proposition 1"}, {"text": "with respect to f and q:", "cite_spans": [], "ref_spans": [], "section": "Proof of Proposition 1"}, {"text": "To show that the contract is coordinating, we should demonstrate that f = f * and q = q * satisfy the optimality conditions. Showing the optimality of q = q * for f = f * leads to:", "cite_spans": [], "ref_spans": [], "section": "Proof of Proposition 1"}, {"text": "Next, to show that a fixed two-part subsidy cannot coordinate this market we consider two cases: (i)F \u2265\u016a q * , and (ii)F <\u016a q * .", "cite_spans": [], "ref_spans": [], "section": "Proof of Proposition 1"}, {"text": "(i) Suppose that f * =\u016a q * \u2264F . Then taking the left derivative of manufacturer's profit at f * leads to", "cite_spans": [], "ref_spans": [], "section": "Proof of Proposition 1"}, {"text": "Therefore, the left derivative is negative and the optimal value of f under the contract will not be the same as f * =\u016a q * .", "cite_spans": [], "ref_spans": [], "section": "Proof of Proposition 1"}, {"text": "as s(f) = \u03b8f by the definition of subsidy in this region. On the other hand,", "cite_spans": [], "ref_spans": [], "section": "Proof of Proposition 1"}, {"text": "Note that f * =F in the case of\u016a q * \u2265F . Therefore,", "cite_spans": [], "ref_spans": [], "section": "Proof of Proposition 1"}, {"text": "Furthermore, in the case of f * =\u016a q * <F , by the definition of the subsidy we have", "cite_spans": [], "ref_spans": [], "section": "Proof of Proposition 1"}, {"text": "As a result f = f * when q = q * leading to the desired result. Marginal production cost of a vaccine e Production subsidy per vaccine J (\u00b7), j(\u00b7)", "cite_spans": [], "ref_spans": [], "section": "Proof of Proposition 1"}, {"text": "Probability distribution and density functions of U f", "cite_spans": [], "ref_spans": [], "section": "D Notational Summary"}, {"text": "Vaccine coverage level F ,F Critical vaccination fraction;F = min{F, 1} g Realized coverage level; g = min{U q, f } L Maximum possible cost from an infection to a consumer with u = 1 p(f ), P (f ) Infection probability for the vaccinated and unvaccinated populations q Normalized target production level r(f ) Infection probability for the entire population R0", "cite_spans": [], "ref_spans": [], "section": "D Notational Summary"}, {"text": "Basic reproduction number s Subsidy given to each vaccinated consumer SC Realized total social cost SW Expected total social welfare T ", "cite_spans": [], "ref_spans": [], "section": "D Notational Summary"}], "bib_entries": {"BIBREF0": {"ref_id": "b0", "title": "Potential Public Health Impact of Imperfect HIV Type 1 Vaccines", "authors": [{"first": "R", "middle": [], "last": "Anderson", "suffix": ""}, {"first": "M", "middle": [], "last": "Hanson", "suffix": ""}], "year": 2005, "venue": "Journal of Infectious Diseases", "volume": "191", "issn": "", "pages": "85--96", "other_ids": {}}, "BIBREF1": {"ref_id": "b1", "title": "The Theoretical Population-Level Impact of a Prophylactic Human Papilloma Virus Vaccine", "authors": [{"first": "J", "middle": ["P"], "last": "Hughes", "suffix": ""}, {"first": "G", "middle": ["P"], "last": "Garnett", "suffix": ""}, {"first": "L", "middle": [], "last": "Koutsky", "suffix": ""}], "year": 2002, "venue": "Epidemiology", "volume": "13", "issn": "", "pages": "", "other_ids": {}}, "BIBREF2": {"ref_id": "b2", "title": "Imperfect Vaccines and Herd Immunity to HIV", "authors": [{"first": "A", "middle": ["R"], "last": "Mclean", "suffix": ""}, {"first": "S", "middle": ["M"], "last": "Blower", "suffix": ""}], "year": 1993, "venue": "Proceedings of the Royal Society of London. Series B: Biological Sciences 253", "volume": "", "issn": "", "pages": "", "other_ids": {}}}, "ref_entries": {"FIGREF0": {"text": "Actual and Approximated Values of p(f ) for R 0 = 2 and \u03c6 = 0.9", "latex": null, "type": "figure"}, "FIGREF1": {"text": "(f ) T (f ) = r(f ) \u2212 p(f ) uIndex of consumers' relative cost from an infection uIndex of a consumer indifferent between getting or not getting the vaccineU Fractional yield; 0 < U \u2264\u016a , E[U ] = \u00b5 W , w(Normalized) price of a vaccine; Normalized loss to the society per infection \u00b5 \u00b5 = E[U ] \u03a0 , \u03c0 Realized and expected profit of the manufacturer \u03c1(\u00b7) Hazard rate; \u03c1(z) = j(z) 1\u2212J(z) \u03c3M Manufacturer's expected surplus \u03c3V , \u03c3N Expected surplus for the vaccinated and unvaccinated consumers \u03c3S Expected societal surplus \u03c6 Effectiveness of a vaccine", "latex": null, "type": "figure"}, "TABREF1": {"text": "Notational Symbols and Their Meanings", "latex": null, "type": "table", "html": "<html><body><table><tr><td>Symbol </td><td>\u00a0</td><td>Meaning\n</td><td>Symbol </td><td>Meaning\n</td></tr><tr><td>c </td><td>Marginal production cost of a vaccine\n</td><td>\u0393 </td><td>Expected total social cost\n</td></tr><tr><td>e </td><td>Production subsidy per vaccine\n</td><td>\u03b7 </td><td>A constant; 0 \u2264 \u03b7 </td><td>\u2264 1 1\u2212\u03c6\n</td></tr><tr><td>J(\u00b7), j(\u00b7) </td><td>Probability distribution and density func-\n</td><td>\u03b8 </td><td>\u03b8 = 1 \u2212 \u03b7(1 \u2212 \u03c6)\n</td><td>\u00a0</td></tr><tr><td>tions of U\n</td><td>\u03bb </td><td>Normalized loss to the society per infection\n</td></tr><tr><td>f </td><td>Vaccine coverage level\n</td><td>\u00b5 </td><td>\u00b5 = E[U ]\n</td><td>\u00a0</td></tr><tr><td>F , F\u0304 </td><td>Critical vaccination fraction; F\u0304 = min{F, 1}\n</td><td>\u03a0 , \u03c0 </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>g </td><td>Realized coverage level; g = min{Uq, f}\n</td><td>\u00a0</td><td>turer\n</td><td>Realized and expected profit of the manufac-\n</td></tr><tr><td>L </td><td>a consumer with u </td><td>Maximum possible cost from an infection to = 1\n</td><td>\u03c1(\u00b7) </td><td>Hazard rate; \u03c1(z) = j(z)1\u2212J(z)\n</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u03c3M </td><td>Manufacturer's expected surplus\n</td></tr><tr><td>p(f), P (f) </td><td>Infection probability for the vaccinated and unvaccinated populations\n</td><td>\u03c3V , \u03c3N </td><td>Expected surplus for the vaccinated and unvaccinated consumers\n</td></tr><tr><td>q </td><td>Normalized target production level\n</td><td>\u03c3S </td><td>Expected societal surplus\n</td></tr><tr><td>r(f) </td><td>Infection probability for the entire population\n</td><td>\u03c6 </td><td>Effectiveness of a vaccine\n</td></tr><tr><td>R0 </td><td>Basic reproduction number\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>s </td><td>Subsidy given to each vaccinated consumer\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>SC </td><td>Realized total social cost\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>SW </td><td>Expected total social welfare\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>T (f) </td><td>T (f) = r(f) \u2212 p(f) fection\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>u </td><td>Index of consumers' relative cost from an in-\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u0304 u</td><td>Index of a consumer indifferent between getting or not getting the vaccine\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>U </td><td>Fractional yield; 0 </td><td>&lt; U \u2264 U\u0304 , E[U ] = \u00b5\n(Normalized) price of a vaccine; w = W\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>W , w </td></tr></table></body></html>"}}, "back_matter": [{"text": "(ii) Suppose that f * =F <\u016a q * . Then taking the right derivative of manufacturer's profit at f * leads to \u2202\u03c0(q * , f) \u2202fTherefore, for any non-zero subsidy to consumers, the right derivative will be positive and the optimal value of f under the contract will not be the same as f * =F .", "cite_spans": [], "ref_spans": [], "section": "annex"}, {"text": "We first take the derivative ofwith respect to f and q: We demonstrate that f = f * and q = q * in (??) satisfy the optimality conditions. Showing the optimality of q = q * for f = f * is straightforward as:Next, we show that f * is the optimal vaccine demand for q = q * . For this purpose, we show that ", "cite_spans": [], "ref_spans": [], "section": "Proof of Theorem 3"}]}